These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Acute influence of FK506 on T-lymphocyte populations of peripheral blood and spleen in rats.
    Author: Wang M, Li N, Zhang Q, Ma J, Li Q.
    Journal: Transplant Proc; 2007; 39(1):292-4. PubMed ID: 17275526.
    Abstract:
    BACKGROUND: Tacrolimus (FK506) is an immunosuppressive agent used in clinical transplantation. We studied the acute impact of FK506 on T-lymphocyte populations of peripheral blood and spleen in rats. METHODS: The animals injected with FK506 (2 mg/kg) subcutaneously were sacrificed at 12, 24, or 48 hours after administration. CD3(+), CD4(+) and CD8(+) T-cell populations in peripheral blood and spleen were analyzed by FACS. RESULTS: After treatment with FK506, the proportion of CD4(+) cells significantly increased in the spleen at 12 hours, decreasing to control levels at 24 and 48 hours. There was a slight increase in the CD4(+) subpopulation in the peripheral blood at 12 and 24 hours and a significant increase at 48 hours. The CD8(+) T-cell subpopulations in peripheral blood and spleen were stable during FK506 administration. CONCLUSIONS: These results indicated that FK506 increased CD4(+) spleen lymphocyte activation in a short time, inducing a subsequent increase in CD4(+) cells subsets in peripheral blood.
    [Abstract] [Full Text] [Related] [New Search]